Cantor Fitzgerald Estimates Gilead Sciences FY2025 Earnings
Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) – Equities researchers at Cantor Fitzgerald issued their FY2025 earnings per share (EPS) estimates for Gilead Sciences in a research report issued on Tuesday, April 22nd. Cantor Fitzgerald analyst C. Gould expects that the biopharmaceutical company will post earnings per share of $7.93 for the year. Cantor Fitzgerald […]
Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) – Equities researchers at Cantor Fitzgerald issued their FY2025 earnings per share (EPS) estimates for Gilead Sciences in a research report issued on Tuesday, April 22nd. Cantor Fitzgerald analyst C. Gould expects that the biopharmaceutical company will post earnings per share of $7.93 for the year. Cantor Fitzgerald […]
